PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLCGeorge R. Blumenschein, Craig H. Reynolds, Edward B. Garon et al.|Journal of Thoracic Oncology|2016Cited by 5